cyclosporine has been researched along with Protein-Losing Enteropathies in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, SI; Kishida, D; Kobayashi, Y; Kondo, Y; Miyazaki, D; Sekijima, Y; Shimojima, Y; Takamatsu, R | 1 |
Hashimura, Y; Hayakawa, A; Iijima, K; Kanegane, H; Matsuo, M; Miyawaki, T; Nakanishi, K; Nozu, K; Takemoto, M; Yoshikawa, N | 1 |
Chang, YS; Chen, WS; Chou, CT; Lai, CC; Tsai, CY; Wang, SH | 1 |
Gakiya, I; Hokama, A; Kinjo, F; Kugai, Y; Matayoshi, R; Saito, A; Sunagawa, T; Tomiyama, R; Yonamine, Y | 1 |
Jenkins, HR; Jewkes, FE; Lord, R; Verrier Jones, K | 1 |
1 review(s) available for cyclosporine and Protein-Losing Enteropathies
Article | Year |
---|---|
Protein-losing Gastroenteropathy Related to Mixed Connective Tissue Disease: A Case Report of a Successful Outcome and Literature Review.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hypoalbuminemia; Immunosuppressive Agents; Mixed Connective Tissue Disease; Prednisolone; Protein-Losing Enteropathies; Radionuclide Imaging; Technetium Tc 99m Aggregated Albumin | 2017 |
4 other study(ies) available for cyclosporine and Protein-Losing Enteropathies
Article | Year |
---|---|
Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Topics: CD4-Positive T-Lymphocytes; Child, Preschool; Cyclosporine; DNA; Forkhead Transcription Factors; Gene Deletion; Genetic Diseases, X-Linked; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Male; Methylprednisolone; Nephrotic Syndrome; Polyendocrinopathies, Autoimmune; Protein-Losing Enteropathies; Secondary Prevention; Sequence Analysis, DNA; T-Lymphocytes, Regulatory; Treatment Outcome | 2009 |
Protein-losing enteropathy and premature ovarian failure in a young woman with systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Oophoritis; Polyendocrinopathies, Autoimmune; Primary Ovarian Insufficiency; Protein-Losing Enteropathies; Treatment Outcome | 2012 |
Successful long-term treatment with cyclosporin A in protein losing gastroenteropathy.
Topics: Administration, Oral; Biopsy, Needle; CREST Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Duodenum; Female; Follow-Up Studies; Humans; Immunohistochemistry; Immunosuppressive Agents; Long-Term Care; Middle Aged; Protein-Losing Enteropathies; Radionuclide Imaging; Risk Assessment; Severity of Illness Index; Stomach; Treatment Outcome | 2004 |
Absorption of a new oral formulation of cyclosporin A in a child on parenteral nutrition.
Topics: Administration, Oral; Child, Preschool; Cyclosporine; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Diseases; Kidney Transplantation; Male; Parenteral Nutrition, Total; Protein-Losing Enteropathies | 1995 |